CLINICAL TRIALS PROFILE FOR IONSYS
✉ Email this page to a colleague
All Clinical Trials for IONSYS
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00665522 ↗ | A Prospective Safety Surveillance Study of Fentanyl Iontophoretic Transdermal System (40 Mcg) | Terminated | Alza Corporation, DE, USA | 2007-12-01 | The purpose of the study is to document the use of fentanyl HCl 40 mcg system under routine conditions and obtain a more comprehensive understanding of the safety of the system and complications that may not be spontaneously reported. | |
| NCT00666393 ↗ | An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients | Withdrawn | Alza Corporation, DE, USA | Phase 3 | 2008-10-01 | The purpose of this study is to evaluate the safety and clinical utility of fentanyl HCl 40 mcg system for the management of postoperative pain in pediatric inpatients. |
| NCT00708318 ↗ | Study Evaluating Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Normal Healthy Subjects | Completed | YM BioSciences | Phase 1 | 2001-10-01 | This was a pilot, phase I, two-period, fasting, bioavailability, safety,and pharmacokinetic study evaluating single dose of i.v. fentanyl (200 µg) and single doses of 2 mL or 3 mL inhaled AeroLEF (500 µg/mL) delivered by nebulization with the AeroEclipse BAN device administered in normal healthy non-smoking subjects. |
| NCT00779038 ↗ | Safety and Efficacy Study of Fentanyl Iontophoretic Transdermal System (ITS) for Management of Moderate to Severe Acute Pain in Participants Who Have Undergone Elective Spine or Orthopedic Surgery | Terminated | Janssen Cilag N.V./S.A. | Phase 4 | 2008-08-01 | The purpose of this study is to evaluate in daily clinical practice the safety and efficacy of fentanyl Iontophoretic Transdermal (through the skin) System (ITS) for management of moderate (medium level of seriousness) to severe (very serious) acute (a quick and severe) pain in participants who have undergone elective spine or orthopedic (related to bones) surgery. |
| NCT01804673 ↗ | A Study to Evaluate the Safety and Tolerability of Fentanyl Iontophoretic Transdermal System (Fentanyl-ITS) in the Management of Post-Surgery Pain | Terminated | Janssen-Cilag G.m.b.H | Phase 4 | 2008-03-01 | The purpose of this study is to evaluate the safety and tolerability of the fentanyl iontophoretic transdermal (through the skin) system (fentanyl-ITS) in daily clinical practice for management of acute (a quick and severe form of illness in its early stage) moderate to severe post-operative pain (pain after surgery) including the comprehensibility and usefulness of the accompanying information material. |
| NCT02395653 ↗ | Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants | Completed | Incline Therapeutics, Inc. | Phase 3 | 2015-06-29 | The objective of this study is to evaluate the safety and clinical utility of the active, SSEC fentanyl 40 micrograms (mcg) for the management of acute, postoperative pain in pediatric participants. |
| NCT02395653 ↗ | Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants | Completed | The Medicines Company | Phase 3 | 2015-06-29 | The objective of this study is to evaluate the safety and clinical utility of the active, SSEC fentanyl 40 micrograms (mcg) for the management of acute, postoperative pain in pediatric participants. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for IONSYS
Condition Name
Clinical Trial Locations for IONSYS
Trials by Country
Clinical Trial Progress for IONSYS
Clinical Trial Phase
Clinical Trial Sponsors for IONSYS
Sponsor Name
